Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

New Protease Inhibitors for the Treatment of Chronic Hepatitis C

(2013) Shan Liu et al.   ANNALS OF INTERNAL MEDICINE

The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007

(2013) Kathleen N. Ly et al.   ANNALS OF INTERNAL MEDICINE

Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C

(2013) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C

(2013) Edward J. Gane et al.   NEW ENGLAND JOURNAL OF MEDICINE

Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

(2012) Peter Vickerman et al.   ADDICTION

Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis

(2012) Rositsa B. Dimova et al.   CLINICAL INFECTIOUS DISEASES

Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland

(2012) Hamish A. Innes et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution

(2012) Lin Liu et al.   HEPATOLOGY

The changing therapeutic landscape for hepatitis C

(2012) Gregory J Dore   MEDICAL JOURNAL OF AUSTRALIA

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia

(2012) Margaret E Hellard et al.   MEDICAL JOURNAL OF AUSTRALIA

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

(2011) Katy M. E. Turner et al.   ADDICTION

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations

(2011) Natasha K. Martin et al.   HEPATOLOGY

Changes in Blood-borne Infection Risk Among Injection Drug Users

(2011) Shruti H. Mehta et al.   JOURNAL OF INFECTIOUS DISEASES

A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs

(2011) H. Hagan et al.   JOURNAL OF INFECTIOUS DISEASES

Mathematical modelling of hepatitis C treatment for injecting drug users

(2011) Natasha K. Martin et al.   JOURNAL OF THEORETICAL BIOLOGY

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

(2011) Paul K Nelson et al.   LANCET

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

(2011) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

HALTING HIV/AIDS Epidemics

(2011) J. Cohen   SCIENCE

Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs

(2010) Irmgard Zeiler et al.   DRUG AND ALCOHOL DEPENDENCE

Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere

(2010) Peter Vickerman et al.   DRUG AND ALCOHOL DEPENDENCE

Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support

(2010) Jason Grebely et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Hepatitis C testing and treatment among active drug users in Amsterdam

(2010) Catharina E.A. Lindenburg et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Successful Integration of Hepatitis C Evaluation and Treatment Services With Methadone Maintenance

(2010) Kenneth A. Harris et al.   Journal of Addiction Medicine

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

(2010) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

(2010) Bradley M Mathers et al.   LANCET

Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention

(2009) Lucy Burns et al.   ADDICTION

Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting

(2009) Christina Kim et al.   BMC PUBLIC HEALTH

Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence

(2009) Margaret Hellard et al.   CLINICAL INFECTIOUS DISEASES

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents

(2009) J. Grebely et al.   JOURNAL OF VIRAL HEPATITIS

Mortality among injecting drug users in Melbourne: A 16-year follow-up of the Victorian Injecting Cohort Study (VICS)

(2008) Mark A. Stoové et al.   DRUG AND ALCOHOL DEPENDENCE

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users

(2008) Campbell Kynoch Aitken et al.   HEPATOLOGY

Estimating the prevalence of ex-injecting drug use in the population

(2008) MJ Sweeting et al.   STATISTICAL METHODS IN MEDICAL RESEARCH